Webinar Archive: 11 Market Access Questions to Address Prior to Launching Your First Specialty Drug
Getting answers to the eleven key questions covered in this webinar will help guide commercial teams in effectively launching specialty products.
Learning Objectives Covered in the Webinar:
-
- Identify the types of third-party organizations that can help support your specialty drug launch
- Understand the key considerations and composition of establishing third-party partnerships
- Determine the difference between having greater access or greater control, and how that can impact the commercial success of your launch
Market access considerations can be complex to navigate and overwhelming to address for biopharmaceutical commercial teams launching their first specialty drug. That’s where Archbow’s team of market access experts can help. Contact us today to get started.
For additional insights on this topic, you may also enjoy the following blog posts:
Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.
Share in
Recent Posts
Digital Solutions in Patient Services
An Interview on Best Practices and Trends in 2025
Managing Your Network: Are Your Specialty Pharmacies Meeting Program Expectations?
Discover four essential strategies manufacturers need to transform their Specialty Pharmacy networks into efficient powerhouses to enhance patient care, foster innovative HCP relationships, build robust payer partnerships, and ensure product accessibility.
Designing a Pharma Hub for Combination Products
Designing a pharmaceutical hub for combination or companion products is a complex undertaking that requires careful planning and design execution.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|